Omega Fund Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Omega Fund Management, LLC

  • $76.7 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$4.08 - $5.66 $970,525 - $1.35 Million
237,874 Added 10.46%
2,512,705 $11.2 Million
Q2 2021

Aug 16, 2021
BUY
$5.01 - $7.48 $3.57 Million - $5.33 Million
712,331 Added 45.59%
2,274,831 $12.4 Million
Q4 2020

Feb 16, 2021
BUY
$6.66 - $14.66 $10.4 Million - $22.9 Million
1,562,500 New
1,562,500 $17 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email